Global $11 Billion Non-Hodgkin Lymphoma Market Outlook, 2024-2029: Focus on T-cell Lymphoma and Immunotherapies
May 01, 2024 05:52 ET
|
Research and Markets
Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Non-Hodgkin Lymphoma Pipeline Landscape 2024: Analysis of Over 220 Potential Pharmaceuticals in Development
April 25, 2024 07:41 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Non-Hodgkin Lymphoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.A new comprehensive report has emerged,...
Asia Pacific Non Hodgkin Lymphoma Therapeutics Market Report: Market Poised for Accelerated Growth with Robust 9.3% CAGR Forecasted from 2023 to 2030
February 20, 2024 11:37 ET
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Asia Pacific Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By...
Global Non Hodgkin Lymphoma Therapeutics Market Predicted to Reach $16.8 Billion by 2030 at a CAGR of 8.4%
February 16, 2024 04:16 ET
|
Research and Markets
Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "Global Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy...
Global Non-Hodgkin Lymphoma Therapeutics Market - Immunotherapy and Targeted Therapies Drive Market Growth
August 11, 2023 04:58 ET
|
Research and Markets
Dublin, Aug. 11, 2023 (GLOBE NEWSWIRE) -- The "Non-Hodgkin Lymphoma Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for NHL...